Home - CF AMR Syndicate

Bridging the translational gap to accelerate antimicrobial and diagnostic innovation for CF lung infections and beyond.

Convene and Explore

Unlock insights opportunities through the network

About Target Product Profiles, a document by the CF AMR Syndicate

Enable Discovery

Build tools and platforms to address sector barriers

Join the CF AMR Syndicate Network for Cystic Fibrosis Research

Accelerate the solution

Deliver collaborative programmes that drive the pipeline

Scientists working on drug discovery for Cystic Fibrosis AMR, Image by Cambridge Laboratory of Molecular Biology

About

Learn more about the CF AMR Syndicate

Who we are

In 2019, Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis Syndicate in Antimicrobial Resistance. The Syndicate expanded, welcoming LifeArc in a tripartite managing partnership.

The CF Syndicate in AMR is a cross-sector initiative that brings together leading experts in CF/AMR from industry, academia, and the clinic with people with Cystic Fibrosis. The collective expertise of the CF AMR Syndicate enables new efforts in the discovery of CF antimicrobials to accelerate translation to the clinic and ultimately bring better treatment options to people affected by CF faster.

Learn more about us

CF AMR Network

Our network facilitates collaboration and knowledge exchange in CF infection research and aims to create a diverse cross-sector collaborative network with the expertise and drive required to drive and accelerate CF antimicrobial development.

Join our network and be part of a collaborative force driving groundbreaking cystic fibrosis antimicrobial research.

Together, we can accelerate the development of new treatments and improve the lives of people with CF.

CF AMR network

Connect with experts

Bringing together a critical mass of individuals and organisations with expertise and capabilities in CF antimicrobial discovery and development.

Join our network

Collaborate effectively

Join our network and be part of a collaborative force driving groundbreaking cystic fibrosis antimicrobial research. Together, we can accelerate the development of new treatments and improve the lives of those affected by this disease.

Join our network

Facilitate discovery

Drive and facilitate introductions across the network to enable collaborative projects, strengthening national and international collaboration in CF antimicrobial research.

Join our network